StockData

Nika Pharmaceuticals, Inc (NIKA) stock

NIKAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 0/30
$0.41+0.00 (0.00%)

Close on Oct 16, 2026Market cap $431.19MP/E –Yield –

Nika Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Nika Pharmaceuticals

Nika Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Nika Pharmaceuticals figures

See a number that looks wrong?